103797-19-9 Usage
General Description
4-Tert-butyl-2-nitrobenzoic acid is a chemical compound with the molecular formula C11H13NO4. The compound consists of a benzoic acid molecule - a carboxylic acid consisting of a benzene ring substituted by a carboxyl group (COOH) - further substituted by a tert-butyl group and a nitro group in the 4- and 2- positions respectively. The tert-butyl group renders the compound more bulky, while the nitro group is a typical "electron-withdrawing" group and can make the molecule more reactive. 4-Tert-butyl-2-nitro-benzoic acid is used in organic synthesis and can be used to make other chemical compounds such as dyes, polymers, pharmaceuticals, and other industrially relevant compounds. Its exact properties, such as melting point and boiling point, will depend on the conditions such as pressure and temperature, and it may pose hazards such as being irritative to skin and eyes or being harmful if inhaled or swallowed. Therefore, proper safety measures should be taken when handling it.
Check Digit Verification of cas no
The CAS Registry Mumber 103797-19-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,3,7,9 and 7 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 103797-19:
(8*1)+(7*0)+(6*3)+(5*7)+(4*9)+(3*7)+(2*1)+(1*9)=129
129 % 10 = 9
So 103797-19-9 is a valid CAS Registry Number.
InChI:InChI=1/C11H13NO4/c1-11(2,3)7-4-5-8(10(13)14)9(6-7)12(15)16/h4-6H,1-3H3,(H,13,14)
103797-19-9Relevant articles and documents
DUAL AGONISTS OF FXR AND PPARδ AND THEIR USES
-
Page/Page column 39; 59, (2019/04/16)
The present invention relates to small molecule compounds and their use as agonists of farnesoid X receptor (FXR) and/or peroxisome proliferator activated receptor delta (PPARδ). The present invention also relates to the use of said compounds in the treatment of metabolic diseases and respective methods of treatment.
Meta-Oligoazobiphenyls - Synthesis via site-selective Mills reaction and photochemical properties
Reuter, Raphael,Wegner, Hermann A.
supporting information; experimental part, p. 877 - 883 (2012/07/17)
The investigation of multi-photochromic compounds constitutes a great challenge, not only from a synthetic point of view, but also with respect to the analysis of the photochemical properties. In this context we designed a novel strategy to access meta-ol
AMINOQUINAZOLINE CANNABINOID RECEPTOR MODULATORS FOR TREATMENT OF DISEASE
-
Page/Page column 201, (2009/01/23)
The present invention relates to compounds and methods useful as modulators of CB2 for the treatment or prevention of disease states including, but not limited to pain, autoimmune disease, malabsorption syndrome, pulmonary disease, osteoporosis, muscle spasm in cancer, neuromuscular disorder, and atherosclerosis progression.
